Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice

PLoS ONE

Volumn 4, Issue 1, 2009, Pages

  Zhao, Yong ^a   Lin, Brian ^a   Darflinger, Robert ^a   Zhang, Yongkang ^a   Holterman, Mark J ^a   Skidgel, Randal A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; L SELECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL FUNCTION; CELL INFILTRATION; CELL REGENERATION; CELL THERAPY; CELL VOLUME; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; INSULITIS; LEUKOCYTE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; TREATMENT RESPONSE; ANIMAL; BIOSYNTHESIS; BLOOD; CYTOLOGY; DISEASE COURSE; FETUS BLOOD; IMMUNOLOGY; METABOLISM; PANCREAS ISLET; STEM CELL;

MUS;

ANIMALS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; FETAL BLOOD; HYPERGLYCEMIA; ISLETS OF LANGERHANS; L-SELECTIN; MICE; MICE, INBRED NOD; STEM CELLS; T-LYMPHOCYTES, REGULATORY;

EID: 64149099299     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004226     Document Type: Article

References (43)

1. Trucco M (2005) Regeneration of the pancreatic beta cell. J Clin Invest 115: 5-12.
2. Zhao Y, Glesne D, Huberman E (2003) A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A 100: 2426-2431.
3. Zhao Y, Wang H, Mazzone T (2006) Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics. Exp Cell Res 312: 2454-2464.
4. Ricordi C, Hering BJ, Shapiro AM (2008) Beta-cell transplantation for diabetes therapy. Lancet 372: 27-28.
5. Ablamunits V, Sherry NA, Kushner JA, Herold KC (2007) Autoimmunity and beta cell regeneration in mouse and human type 1 diabetes: the peace is not enough. Ann N Y Acad Sci 1103: 19-32.
6. Bonner-Weir S, Weir GC (2005) New sources of pancreatic beta-cells. Nat Biotechnol 23: 857-861.
7. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA (2008) In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature.
8. Bluestone JA, Tang Q, Sedwick CE (2008) T Regulatory Cells in Autoimmune Diabetes: Past Challenges, Future Prospects. J Clin Immunol.
9. Bresson D, Togher L, Rodrigo E, Chen Y, Bluestone JA, et al. (2006) Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs. J Clin Invest 116: 1371-1381.
10. Chatenoud L, Bach JF (2005) Resetting the functional capacity of regulatory T cells: a novel immunotherapeutic strategy to promote immune tolerance. Expert Opin Biol Ther 5 Suppl 1: S73-S81.
11. Chatenoud L, Bach JF (2005) Regulatory T cells in the control of autoimmune diabetes: the case of the NOD mouse. Int Rev Immunol 24: 247-267.
12. Roncarolo MG, Battaglia M (2007) Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 7: 585-598.
13. Tarbell KV, Petit L, Zuo X, Toy P, Luo X, et al. (2007) Dendritic cell-expanded, islet-specific CD4+CD25+CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med 204: 191-201.
14. You S, Slehoffer G, Barriot S, Bach JF, Chatenoud L (2004) Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice. Proc Natl Acad Sci U S A 101 Suppl 2: 14580-14585.
15. Li Q, Xu B, Michie SA, Rubins KH, Schreriber RD, et al. (2008) Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. Proc Natl Acad Sci U S A 105: 12439-12444.
16. Schneider A, Rieck M, Sanda S, Pihoker C, Greenbaum C, et al. (2008) The effector T cells of diabetic subjects are resistant to regulation via CD4+FOXP3+ regulatory T cells. J Immunol 181: 7350-7355.
17. Tang Q, Adams JY, Penaranda C, Melli K, Piaggio E, et al. (2008) Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28: 687-697.
18. Zehn D, Bevan MJ (2006) T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity. Immunity 25: 261-270.
19. Allen JS, Pang K, Skowera A, Ellis R, Rackham C, et al. (2008) Plasmacytoid dendritic cells are proportionally expanded at diagnosis of Type 1 diabetes and enhance islet autoantigen presentation to T cells through immune complex capture. Diabetes.
20. Huang Y, Fugier-Vivier IJ, Miller T, Elliott MJ, Xu H, et al. (2008) Plasmacytoid precursor dendritic cells from NOD mice exhibit impaired function: are they a component of diabetes pathogenesis? Diabetes 57: 2360-2370.
21. Jin Y, Chen X, Podolsky R, Hopkins D, Makala LH, et al. (2008) APC dysfunction is correlated with defective suppression of T cell proliferation in human type 1 diabetes. Clin Immunol.
22. Marleau AM, Summers KL, Singh B (2008) Differential contributions of APC subsets to T cell activation in nonobese diabetic mice. J Immunol 180: 5235-5249.
23. Summers KL, Marleau AM, Mahon JL, McManus R, Hramiak I, et al. (2006) Reduced IFN-alpha secretion by blood dendritic cells in human diabetes. Clin Immunol 121: 81-89.
24. Kukreja A, Cost G, Marker J, Zhang C, Sun Z, et al. (2002) Multiple immunoregulatory defects in type-1 diabetes. J Clin Invest 109: 131-140.
25. Pop SM, Wong CP, Culton DA, Clarke SH, Tisch R (2005) Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes. J Exp Med 201: 1333-1346.
26. You S, Belghith M, Cobbold S, Alyanakian MA, Gouarin C, et al. (2005) Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes 54: 1415-1422.
27. Bayry J, Lacroix-Desmazes S, Dasgupta S, Kazatchkine MD, Kaveri SV (2008) Efficacy of regulatory T-cell immunotherapy: are inflammatory cytokines key determinants? Nat Rev Immunol 8: 1p.
28. Brusko T, Wasserfall C, McGrail K, Schatz R, Viener HL, et al. (2007) No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes 56: 604-612.
29. Brusko TM, Wasserfall CH, Clare-Salzler MJ, Schatz DA, Atkinson MA (2005) Functional defects and the influence of age on the frequency of CD4+CD25+ T-cells in type 1 diabetes. Diabetes 54: 1407-1414.
30. Gombert JM, Herbelin A, Tancrede-Bohin E, Dy M, Chatenoud L, et al. (1996) Early defect of immunoregulatory T cells in autoimmune diabetes. C R Acad Sci III 319: 125-129.
31. Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, et al. (2005) Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54: 92-99.
32. Tritt M, Sgouroudis E, d'Hennezel E, Albanese A, Piccirillo CA (2008) Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes. Diabetes 57: 113-123.
33. Zhao Y, Huang Z, Qi M, Lazzarini P, Mazzone T (2007) Immune regulation of T lymphocyte by a newly characterized human umbilical cord blood stem cell. Immunol Lett 108: 78-87.
34. Abdi R, Fiorina P, Adra CN, Atkinson M, Sayegh MH (2008) Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes 57: 1759-1767.
35. Meier JJ, Lin JC, Butler AE, Galasso R, Martinez DS, et al. (2006) Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 49: 1838-1844.
36. Li MO, Flavell RA (2008) TGF-beta: a master of all T cell trades. Cell 134: 392-404.
37. Roncarolo MG, Battaglia M, Gregori S (2003) The role of interleukin 10 in the control of autoimmunity. J Autoimmun 20: 269-272.
38. Wan YY, Flavell RA (2006) The roles for cytokines in the generation and maintenance of regulatory T cells. Immunol Rev 212: 114-130.
39. Perruche S, Zhang P, Liu Y, Saas P, Bluestone JA, et al. (2008) CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells. Nat Med 14: 528-535.
40. Staeva-Vieira T, Peakman M, von HM (2007) Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes. Clin Exp Immunol 148: 17-31.
41. Nauta AJ, Fibbe WE (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood 110: 3499-3506.
42. Bour-Jordan H, Salomon BL, Thompson HL, Santos R, Abbas AK, et al. (2007) Constitutive expression of B7-1 on B cells uncovers autoimmunity toward the B cell compartment in the nonobese diabetic mouse. J Immunol 179: 1004-1012.
43. Goudy KS, Burkhardt BR, Wasserfall C, Song S, Campbell-Thompson ML, et al. (2003) Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion. J Immunol 171: 2270-2278.